- Home
- ARVN vs SHBI Comparison
ARVN vs SHBI Comparison
Compare ARVN & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SHBI
- Stock Information
- Founded
- ARVN 2015
- SHBI 1876
- Country
- ARVN United States
- SHBI United States
- Employees
- ARVN N/A
- SHBI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SHBI Major Banks
- Sector
- ARVN Health Care
- SHBI Finance
- Exchange
- ARVN Nasdaq
- SHBI Nasdaq
- Market Cap
- ARVN 456.2M
- SHBI 548.7M
- IPO Year
- ARVN 2018
- SHBI N/A
- Fundamental
- Price
- ARVN $7.58
- SHBI $15.77
- Analyst Decision
- ARVN Buy
- SHBI Buy
- Analyst Count
- ARVN 21
- SHBI 2
- Target Price
- ARVN $20.53
- SHBI $20.00
- AVG Volume (30 Days)
- ARVN 1.8M
- SHBI 155.3K
- Earning Date
- ARVN 08-05-2025
- SHBI 07-24-2025
- Dividend Yield
- ARVN N/A
- SHBI 3.00%
- EPS Growth
- ARVN N/A
- SHBI 169.44
- EPS
- ARVN N/A
- SHBI 1.61
- Revenue
- ARVN $426,900,000.00
- SHBI $208,209,000.00
- Revenue This Year
- ARVN $7.57
- SHBI N/A
- Revenue Next Year
- ARVN N/A
- SHBI $7.22
- P/E Ratio
- ARVN N/A
- SHBI $9.94
- Revenue Growth
- ARVN 498.74
- SHBI 24.24
- 52 Week Low
- ARVN $5.90
- SHBI $11.47
- 52 Week High
- ARVN $29.96
- SHBI $17.61
- Technical
- Relative Strength Index (RSI)
- ARVN 48.51
- SHBI 45.41
- Support Level
- ARVN $7.41
- SHBI $15.60
- Resistance Level
- ARVN $8.05
- SHBI $16.84
- Average True Range (ATR)
- ARVN 0.39
- SHBI 0.42
- MACD
- ARVN -0.03
- SHBI -0.15
- Stochastic Oscillator
- ARVN 31.33
- SHBI 13.71
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.